3-(1H-imidazol-2-yl)benzoic acid hydrate, 95.0%, 250mg

Ethyl 5H-pyrimido[4,5-b][1,4]thiazine-6-carboxylate, 97%, 250mg

2-Amino-2-(pyridin-2-yl)ethanol dihydrochloride, 95.0%, 250mg

(S)-Ethyl 2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoate hydrochloride, 95.0%, 1g

4-Cyanophenoxytetrafluorobromoethane, 95.0%, 5g

4-Chlorobenzoylacetonitrile, 97.0%, 10g

Methyl 5-bromo-2-chloroisonicotinate, 95.0%, 10g

2,6-Dimethylbenzoic Acid>98.0%(GC)(T)25g

D(+)-melibiose monohydrate, min. 99%, for biochemistry, 10 g, plastic packaging.

1,3,2-Dioxaborolane, 2-[2-[(3,4-dichlorophenyl)methoxy]phenyl]-4,4,5,5-tetramethyl-, 95%, 1g

GC capillary column ROTI®Cap-5, 50 m, 0.25 mm, 0.35 µm, 1 Piece(s)

3-Iodo-N,N-dimethylbenzamide, 98%, 250mg

Ethyl 6-methylbenzo[b]thiophene-2-carboxylate, 97.0%, 1g